Rabeprazole Impurity 14 | CAS 117977-18-1 - Request Quote
Rabeprazole Impurity 14
| SZ CAT No: | SZ-R006053 |
| CAS No | 117977-18-1 |
| Mol.F. | C11H17NO3 |
| Mol.Wt. | 211.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Rabeprazole Impurity 14 is chemically 4-(3-Methoxypropoxy)-2,3-dimethylpyridine 1-oxide. Rabeprazole Impurity 14 is supplied with detailed characterization data compliant with regulatory guideline. Rabeprazole Impurity 14 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Rabeprazole.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 117977-18-1
Purchase 117977-18-1
Order 117977-18-1
Enquire 117977-18-1
price of 117977-18-1
117977-18-1 Supplier
117977-18-1 Manufacturer
117977-18-1 Exporter
buy high quality Rabeprazole Impurity 14
Purchase Rabeprazole Impurity 14
Rabeprazole Impurity 14 suppliers
Rabeprazole Impurity 14 manufacturers
Rabeprazole Impurity 14 price
Order Rabeprazole Impurity 14
Enquire Rabeprazole Impurity 14
Rabeprazole Impurity 14 cost
Rabeprazole Impurity 14 Supplier
Rabeprazole Impurity 14 Distributor
Rabeprazole Impurity 14 for Method Validation
Rabeprazole Reference Standard
Rabeprazole Impurity 14 for ANDA Filing
Rabeprazole Impurity 14 for Forced Degradation Studies
Rabeprazole Impurity 14 Identification Standards
Rabeprazole Impurity 14 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


